glp 1 gip receptor agonist The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Major physiological roles of GLP-1

International Journal of Molecular Sciences, 25 (9)

We recently covered C8Vantage specifically as well, so if you want to read more about this product (and get the science specific to it), make sure you check out the article on it

Epidemiological studies have demonstrated a correlation between hyperglycemia and the severity of cardiovascular dysfunction and mortality in patients with DM [3, 4]

Study Design The study protocol was reviewed and approved by the Scientific Council of the General Hospital of Athens, Hippocratio (11888/24-6-2009) and it was conducted according to the principles of the Declaration of Helsinki of 1975 as revised in 2013

In people with type 2 diabetes, the results were also promising